Literature DB >> 15734858

Adipocytokines and VLDL metabolism: independent regulatory effects of adiponectin, insulin resistance, and fat compartments on VLDL apolipoprotein B-100 kinetics?

Theodore W K Ng1, Gerald F Watts, Maryam S Farvid, Dick C Chan, P Hugh R Barrett.   

Abstract

We investigated the relationship of plasma adipocytokine concentrations with VLDL apolipoprotein B (apoB)-100 kinetics in men. Plasma adiponectin, leptin, resistin, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-alpha) concentrations were measured using enzyme immunoassays and insulin resistance by homeostasis model assessment (HOMA) score in 41 men with BMI of 22-35 kg/m(2). VLDL apoB kinetics were determined using an intravenous infusion of 1-[(13)C]leucine, gas chromatography-mass spectrometry, and compartmental modeling. Visceral and subcutaneous adipose tissue mass (ATM) were determined using magnetic resonance imaging, and total ATM was measured by bioelectrical impedance. In univariate regression, plasma adiponectin and leptin concentrations were inversely and directly associated, respectively, with plasma triglyceride; HOMA score; and visceral, subcutaneous, and total ATMs. Conversely, adiponectin and leptin were directly and inversely correlated, respectively, with VLDL apoB catabolism and HDL cholesterol concentration (P < 0.05). Resistin, IL-6, and TNF-alpha were not significantly associated with any of these variables. In multivariate regression, adiponectin was the most significant predictor of plasma VLDL apoB concentration (P = 0.001) and, together with total or subcutaneous ATM, was an independent predictor of VLDL apoB catabolism (P < 0.001); HOMA score was the most significant predictor of VLDL apoB hepatic secretion (P < 0.05). Leptin was not an independent predictor of VLDL apoB kinetics. In conclusion, plasma VLDL apoB kinetics may be differentially controlled by adiponectin and insulin resistance, with adiponectin regulating catabolism and insulin resistance regulating hepatic secretion in men. Total body fat may also independently determine the rate of VLDL catabolism, but leptin, resistin, IL-6, and TNF-alpha do not have a significant effect in regulating apoB kinetics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734858     DOI: 10.2337/diabetes.54.3.795

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects.

Authors:  Faidon Magkos; Elisa Fabbrini; Bruce W Patterson; J Christopher Eagon; Samuel Klein
Journal:  Metabolism       Date:  2011-05-31       Impact factor: 8.694

2.  Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population.

Authors:  Lu Wang; Yijin Wang; Shuhong Liu; Xiangwei Zhai; Guangde Zhou; Fengmin Lu; Jingmin Zhao
Journal:  J Gastroenterol       Date:  2019-05-27       Impact factor: 7.527

3.  The evolving relationship between adiponectin and insulin sensitivity in hepatitis C patients during viral clearance.

Authors:  Ming-Ling Chang; Chia-Jung Kuo; Li-Heng Pao; Chen-Ming Hsu; Cheng-Tang Chiu
Journal:  Virulence       Date:  2017-03-07       Impact factor: 5.882

Review 4.  Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Authors:  Petter Bjornstad; Robert H Eckel
Journal:  Curr Diab Rep       Date:  2018-10-17       Impact factor: 4.810

5.  Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo.

Authors:  Nanlan Luo; Xiangdong Wang; B Hong Chung; Mi-Hye Lee; Richard L Klein; W Timothy Garvey; Yuchang Fu
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-19       Impact factor: 4.310

6.  Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice.

Authors:  Xiuhua Sun; Yunan Tang; Xiaobing Tan; Qiong Li; Wei Zhong; Xinguo Sun; Wei Jia; Craig J McClain; Zhanxiang Zhou
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-12-15       Impact factor: 4.052

Review 7.  Genetics of macrovascular complications in diabetes.

Authors:  Frédéric Fumeron; André F Reis; Gilberto Velho
Journal:  Curr Diab Rep       Date:  2006-04       Impact factor: 4.810

8.  Overproduction of large VLDL particles is driven by increased liver fat content in man.

Authors:  M Adiels; M-R Taskinen; C Packard; M J Caslake; A Soro-Paavonen; J Westerbacka; S Vehkavaara; A Häkkinen; S-O Olofsson; H Yki-Järvinen; J Borén
Journal:  Diabetologia       Date:  2006-02-04       Impact factor: 10.122

9.  In treatment-naïve and antiretroviral-treated subjects with HIV, reduced plasma adiponectin is associated with a reduced fractional clearance rate of VLDL, IDL and LDL apolipoprotein B-100.

Authors:  S Das; M Shahmanesh; M Stolinski; F Shojaee-Moradie; W Jefferson; N C Jackson; M Cobbold; P Nightingale; A M Umpleby
Journal:  Diabetologia       Date:  2006-01-24       Impact factor: 10.122

10.  Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques.

Authors:  Uli C Broedl; Corinna Lebherz; Michael Lehrke; Renee Stark; Martin Greif; Alexander Becker; Franz von Ziegler; Janine Tittus; Maximilian Reiser; Christoph Becker; Burkhard Göke; Klaus G Parhofer; Alexander W Leber
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.